Advances in pharmacovigilance initiatives surrounding antimicrobial resistance-Indian perspective

Laxminarayana Kurady Bairy, Veena Nayak, A. Avinash, Sushil Kiran Kunder

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Introduction: In recent years the development of antimicrobial resistance has been accelerating, the discovery of new antimicrobial agents has slowed substantially in past decades. Area covered: This review mainly focuses on the problem of antimicrobial resistance(AMR); the various contributor mechanisms, consequences and future of AMR. The review also highlights the irrational use of antimicrobials, improving their usage and problems associated with pharmacovigilance of antimicrobial resistance. Expert opinion: Pharmacovigilance in the form of surveillance of antibiotic use is being done in 90% of the countries worldwide through the WHONET program developed by WHO. However, the data comes from a limited area of the globe. Data from every part of the world is required, so that there is geographical representation of every region. A major hurdle in quantifying the extent of antimicrobial resistance is the fact that there are several known microbes, that may turn out to be resistant to one or more of the several known antimicrobial agents. The global action plan initiated by WHO, if implemented successfully will definitely reduce AMR and will help in evaluating treatment interventions.

Original languageEnglish
Pages (from-to)1055-1062
Number of pages8
JournalExpert Opinion on Drug Safety
Volume15
Issue number8
DOIs
Publication statusPublished - 02-08-2016

Fingerprint

Pharmacovigilance
Anti-Infective Agents
Expert Testimony
Anti-Bacterial Agents

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Bairy, Laxminarayana Kurady ; Nayak, Veena ; Avinash, A. ; Kunder, Sushil Kiran. / Advances in pharmacovigilance initiatives surrounding antimicrobial resistance-Indian perspective. In: Expert Opinion on Drug Safety. 2016 ; Vol. 15, No. 8. pp. 1055-1062.
@article{c540c23ef0254ee5a6d22fd20d27dcc4,
title = "Advances in pharmacovigilance initiatives surrounding antimicrobial resistance-Indian perspective",
abstract = "Introduction: In recent years the development of antimicrobial resistance has been accelerating, the discovery of new antimicrobial agents has slowed substantially in past decades. Area covered: This review mainly focuses on the problem of antimicrobial resistance(AMR); the various contributor mechanisms, consequences and future of AMR. The review also highlights the irrational use of antimicrobials, improving their usage and problems associated with pharmacovigilance of antimicrobial resistance. Expert opinion: Pharmacovigilance in the form of surveillance of antibiotic use is being done in 90{\%} of the countries worldwide through the WHONET program developed by WHO. However, the data comes from a limited area of the globe. Data from every part of the world is required, so that there is geographical representation of every region. A major hurdle in quantifying the extent of antimicrobial resistance is the fact that there are several known microbes, that may turn out to be resistant to one or more of the several known antimicrobial agents. The global action plan initiated by WHO, if implemented successfully will definitely reduce AMR and will help in evaluating treatment interventions.",
author = "Bairy, {Laxminarayana Kurady} and Veena Nayak and A. Avinash and Kunder, {Sushil Kiran}",
year = "2016",
month = "8",
day = "2",
doi = "10.1080/14740338.2016.1182495",
language = "English",
volume = "15",
pages = "1055--1062",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Informa Healthcare",
number = "8",

}

Advances in pharmacovigilance initiatives surrounding antimicrobial resistance-Indian perspective. / Bairy, Laxminarayana Kurady; Nayak, Veena; Avinash, A.; Kunder, Sushil Kiran.

In: Expert Opinion on Drug Safety, Vol. 15, No. 8, 02.08.2016, p. 1055-1062.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Advances in pharmacovigilance initiatives surrounding antimicrobial resistance-Indian perspective

AU - Bairy, Laxminarayana Kurady

AU - Nayak, Veena

AU - Avinash, A.

AU - Kunder, Sushil Kiran

PY - 2016/8/2

Y1 - 2016/8/2

N2 - Introduction: In recent years the development of antimicrobial resistance has been accelerating, the discovery of new antimicrobial agents has slowed substantially in past decades. Area covered: This review mainly focuses on the problem of antimicrobial resistance(AMR); the various contributor mechanisms, consequences and future of AMR. The review also highlights the irrational use of antimicrobials, improving their usage and problems associated with pharmacovigilance of antimicrobial resistance. Expert opinion: Pharmacovigilance in the form of surveillance of antibiotic use is being done in 90% of the countries worldwide through the WHONET program developed by WHO. However, the data comes from a limited area of the globe. Data from every part of the world is required, so that there is geographical representation of every region. A major hurdle in quantifying the extent of antimicrobial resistance is the fact that there are several known microbes, that may turn out to be resistant to one or more of the several known antimicrobial agents. The global action plan initiated by WHO, if implemented successfully will definitely reduce AMR and will help in evaluating treatment interventions.

AB - Introduction: In recent years the development of antimicrobial resistance has been accelerating, the discovery of new antimicrobial agents has slowed substantially in past decades. Area covered: This review mainly focuses on the problem of antimicrobial resistance(AMR); the various contributor mechanisms, consequences and future of AMR. The review also highlights the irrational use of antimicrobials, improving their usage and problems associated with pharmacovigilance of antimicrobial resistance. Expert opinion: Pharmacovigilance in the form of surveillance of antibiotic use is being done in 90% of the countries worldwide through the WHONET program developed by WHO. However, the data comes from a limited area of the globe. Data from every part of the world is required, so that there is geographical representation of every region. A major hurdle in quantifying the extent of antimicrobial resistance is the fact that there are several known microbes, that may turn out to be resistant to one or more of the several known antimicrobial agents. The global action plan initiated by WHO, if implemented successfully will definitely reduce AMR and will help in evaluating treatment interventions.

UR - http://www.scopus.com/inward/record.url?scp=84979976490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979976490&partnerID=8YFLogxK

U2 - 10.1080/14740338.2016.1182495

DO - 10.1080/14740338.2016.1182495

M3 - Review article

VL - 15

SP - 1055

EP - 1062

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 8

ER -